Today: 19 May 2026
Northern Star Resources stock drops 3% after UBS trims target as Jan. 22 update nears
8 January 2026
1 min read

Northern Star Resources stock drops 3% after UBS trims target as Jan. 22 update nears

Sydney, Jan 8, 2026, 16:51 AEDT — After-hours

  • Northern Star ended down 3% after a weak quarter kept broker caution in play.
  • UBS trimmed its price target but kept a buy call, pointing to a production miss and tighter cash-flow math.
  • Investors now look to Jan. 22 for the miner’s full quarterly numbers and revised cost guidance.

Northern Star Resources Ltd shares ended down 3% at A$24.60 on Thursday, after trading between A$24.57 and A$25.08. The stock is still up about 56% over the past year.

The slide came as UBS analyst Levi Spry trimmed his price target to A$29.45 from A$29.75 while keeping a buy rating, after the miner’s December-quarter output came in below expectations. UBS said production was 348,000 ounces, about 11% under its estimate, and noted the company cut fiscal 2026 guidance to 1.6 million-1.7 million ounces; UBS also lowered its own FY26 estimate to 1.57 million ounces and cut FY26 earnings-per-share forecasts by 14%.

That matters now because investors are trying to judge whether the stumble is a one-off or the start of a rougher run across Northern Star’s main hubs. Simply Wall St said equipment failures and outages at Kalgoorlie, Jundee and Pogo helped drive the weaker quarter and the guidance trim.

A filing dated Jan. 7 showed the company issued 95,284 unquoted performance rights under an employee incentive plan, with the notice indicating some grants went to key management personnel.

Another Jan. 7 filing showed 138,237 performance rights lapsed after employment cessations during the quarter ended Dec. 31.

Gold prices also eased, cutting some of the tailwind that has lifted miners in recent months. Spot gold slipped 0.3% and Bernard Sin, regional director for Greater China at MKS PAMP, said traders were “weighing heightened geopolitical tensions… against macroeconomic signals” ahead of U.S. payrolls data due on Friday. Reuters

The broader Australian market finished higher, but the raw materials sector was the only one to end lower as profit-taking hit miners after recent gains.

Stock Market Today

  • LeMaitre Q1 Performance Trails Surgical Equipment Sector Leaders
    May 19, 2026, 5:33 AM EDT. LeMaitre (NASDAQ:LMAT) reported Q1 revenue of $66.55 million, up 11.2% year-on-year but missed the mark relative to analyst estimates and offered weaker full-year guidance than peers. Despite beating earnings per share (EPS) estimates for the upcoming quarter, LMAT's stock fell 10%, trading at $100.83. In contrast, sector leader Intuitive Surgical (NASDAQ:ISRG) delivered a 23% revenue increase to $2.77 billion, surpassing expectations by 5.8%, driven by its robotic-assisted surgical systems business. The surgical equipment and consumables sector as a whole beat revenue estimates by 2.7% for Q1, with stocks rising an average of 6.4%. Industry growth is underpinned by aging populations and expanding use of AI and robotics, although challenges remain around R&D costs, regulatory compliance, pricing pressures, and potential supply chain issues.

Latest articles

Alphabet Approaches $5 Trillion With Google AI Cloud Move Targeting Nvidia

Alphabet Approaches $5 Trillion With Google AI Cloud Move Targeting Nvidia

19 May 2026
Alphabet shares rose in pre-market trading Tuesday after Google and Blackstone announced a U.S. AI cloud venture, with Blackstone committing $5 billion to add 500 megawatts of data-center capacity by 2027. Alphabet’s Class A shares closed Monday at $396.94 and were quoted at $401.09 before the market opened. The move coincides with the first day of Google I/O and follows strong Q1 earnings.
GeoVax Stock Rockets Nearly 80% as Tiny Vaccine Developer Grabs Biodefense Spotlight

GeoVax Stock Rockets Nearly 80% as Tiny Vaccine Developer Grabs Biodefense Spotlight

19 May 2026
GeoVax Labs shares surged nearly 80% to $2.21 Monday after announcing a $3 million private placement amid heightened interest in biodefense following a WHO emergency alert over Ebola in Africa. The company does not sell an approved Ebola vaccine; its lead candidate targets mpox and smallpox. GeoVax reported $1.3 million in cash at March 31 and a quarterly net loss of $5.3 million. The new funding is expected to close around May 19.
Evolution stock jumps on €2 billion move

Evolution stock jumps on €2 billion move

19 May 2026
Evolution AB shares surged 9% in Stockholm after the company announced a €2 billion share buyback, one of Sweden’s largest. The buyback starts immediately and may run until the 2027 annual meeting, capped at 10% of shares. The OMXS30 index rose just 0.75% in comparison. Evolution also secured a €300 million revolving credit facility from J.P. Morgan SE and Citibank Europe.

Popular

Roblox Shares Jump Almost 10%, Safety Issue Remains Unanswered

Roblox Shares Jump Almost 10%, Safety Issue Remains Unanswered

18 May 2026
Roblox shares rose 9.6% to $46.98 on Monday, bucking declines in the broader tech sector. The jump followed a month-long selloff tied to new child-safety measures, which the company says have reduced user communication and slowed new sign-ups. Roblox cut its 2026 bookings outlook on April 30, but first-quarter revenue and daily active users both rose over 35%. Analysts cited competition from Fortnite and the upcoming Grand Theft Auto VI.
Wall Street jolted by Trump buyback, home-buying moves; S&P 500 slips, Nasdaq steadied by AI
Previous Story

Wall Street jolted by Trump buyback, home-buying moves; S&P 500 slips, Nasdaq steadied by AI

DroneShield Limited stock slips as JPMorgan drops off the 5% holder list — what investors watch next
Next Story

DroneShield Limited stock slips as JPMorgan drops off the 5% holder list — what investors watch next

Go toTop